- JP-listed companies
- Kohjin Bio Co., Ltd.
- Income statement
Kohjin Bio Co., Ltd.【JP:177A】Income statement
Market cap
¥7.3B
P/E ratio
8.9x
| 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 2,276 | 2,826 | 3,251 | 3,947 | 4,743 | 4,770 | 5,206 |
| Cost of revenue | - | - | - | 1,908 | 2,289 | 2,889 | 2,840 |
| Gross profit | - | - | - | 2,039 | 2,454 | 1,881 | 2,366 |
| Gross margin (%) | - | - | - | ||||
| Operating income | - | - | - | 970 | 1,267 | 597 | 991 |
| Operating expenses | - | - | - | 1,070 | 1,187 | 1,284 | 1,375 |
| Income before tax | 75 | 456 | 666 | 918 | 1,244 | 636 | 1,065 |
| Provision for income taxes | - | - | - | 334 | 415 | 251 | 221 |
| Net income | -102 | 303 | 685 | 588 | 830 | 385 | 795 |
| Earnings per share | -302.31 | 896.59 | 2,023.85 | 173.5 | 199.23 | 92.43 | 157.57 |
| Dividend per share | - | 45 | 100 | 100 | 19 | 14 | 24 |